These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37771583)

  • 1. The 1926 novel, "One, no one, one hundred thousand", metaphorizes the potential danger when the immune system is exposed to a repetitive antigen stimulation.
    Ferrazzo F; Leto S; Malara N
    Front Immunol; 2023; 14():1254853. PubMed ID: 37771583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of the Hybridoma Technology on the R&D of Idiotypic Antibodies.
    Kohler H
    Monoclon Antib Immunodiagn Immunother; 2021 Feb; 40(1):2-5. PubMed ID: 33535018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype-Anti-idiotype Fab Complex.
    Wong YH; Goh BC; Lim SY; Teo EW; Lim APC; Dedon PC; Hanson BJ; MacAry PA; Lescar J
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Modulatory Potential of Anti-idiotype Antibodies as a Surrogate of Foot-and-Mouth Disease Virus Antigen.
    Naveed A; Rahman SU; Arshad MI; Aslam B
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central immune system, the self and autoimmunity.
    Sulzer B; Van Hemmen JL; Behn U
    Bull Math Biol; 1994 Nov; 56(6):1009-40. PubMed ID: 7833843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis.
    Zanetti M; Glotz D; Rogers J
    J Immunol; 1986 Nov; 137(10):3140-6. PubMed ID: 3490512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
    Wagner U; Reinsberg J; Krebs D
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
    UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
    J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypic antibody with potential use as an Eimeria tenella sporozoite antigen surrogate for vaccination of chickens against coccidiosis.
    Bhogal BS; Nollstadt KH; Karkhanis YD; Schmatz DM; Jacobson EB
    Infect Immun; 1988 May; 56(5):1113-9. PubMed ID: 3258583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
    Titzer S; Christensen O; Manzke O; Tesch H; Wolf J; Emmerich B; Carsten C; Diehl V; Bohlen H
    Br J Haematol; 2000 Mar; 108(4):805-16. PubMed ID: 10792287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotope vaccines: can they exist?
    McCullough KC; Langley D
    Vaccine; 1985 Mar; 3(1):59-64. PubMed ID: 2408397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of idiotype-anti-idiotype interactions in the activation of self-reactive clones.
    Zaghouani H; Fidanza V; Bona CA
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S19-25. PubMed ID: 2691156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of idiotypic networks in vivo: immunisation with idiotype-bearing (Id1) antibody induces further production of Id1 antibody.
    McCullough KC; Butcher RN
    Immunol Lett; 1991 Jan; 27(1):9-12. PubMed ID: 1708353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
    Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
    Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of anti-idiotype antibodies in COVID-19.
    Shukla AK; Misra S
    J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):727-733. PubMed ID: 36279146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotypic antibodies as immunogens: idiotype-based vaccines.
    Dalgleish AG; Kennedy RC
    Vaccine; 1988 Jun; 6(3):215-20. PubMed ID: 3048008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype.
    Kennedy RC; Adler-Storthz K; Henkel RD; Sanchez Y; Melnick JL; Dreesman GR
    Science; 1983 Aug; 221(4613):853-5. PubMed ID: 6603657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.